EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial Infarction

Erika Csengo, Hajnalka Lorincz iD, Eva Csosz iD, Andrea Guba, Bettina Karai, Judit Toth, Sara Csiha, Gyorgy Paragh, Mariann Harangi iD, Gergely Gyorgy Nagy iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Erika Csengo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Cardiovascular Diseases and Internal Medicine, Borsod-Abauj-Zemplen County Central Hospital and University Teaching Hospital, Szentpéteri k…. Hauptthemen laut MEDLINE: Ubiquinone, Hydroxymethylglutaryl-CoA Reductase Inhibitors, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office - NKFIH, National Research, Development, and Innovation Office—NKFIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coenzyme Q10 (CoQ10) plays a crucial role in facilitating electron transport during oxidative phosphorylation, thus contributing to cellular energy production. Statin treatment causes a decrease in CoQ10 levels in muscle tissue as well as in serum, which may contribute to the musculoskeletal side effects. Therefore, we aimed to assess the effect of newly initiated statin treatment on serum CoQ10 levels after acute ST-elevation myocardial infarction (STEMI) and the correlation of CoQ10 levels with key biomarkers of subclinical or clinically overt myopathy. In this study, we enrolled 67 non-diabetic, statin-naïve early-onset STEMI patients with preserved renal function. Plasma CoQ10 level was determined by ultra-high-performance liquid chromatography–tandem mass spectrometry (UPLC/MS-MS), while the myopathy marker serum fatty acid-binding protein 3 (FABP3) level was measured with enzyme-linked immunosorbent assay (ELISA) at hospital admission and after 3 months of statin treatment. The treatment significantly decreased the plasma CoQ10 (by 43%) and FABP3 levels (by 79%) as well as total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B100 (ApoB100), and oxidized LDL (oxLDL) levels. The change in CoQ10 level showed significant positive correlations with the changes in total cholesterol, LDL-C, ApoB100, and oxLDL levels, while it did not correlate with the change in FABP3 level. Our results prove the CoQ10-reducing effect of statin treatment and demonstrate its lipid-lowering efficacy but contradict the role of CoQ10 reduction in statin-induced myopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquinoneHydroxymethylglutaryl-CoA Reductase InhibitorsST Elevation Myocardial InfarctionHumansMaleFemaleMiddle AgedAgedBiomarkersFatty Acid Binding Protein 3Muscular DiseasesLipoproteins, LDLApolipoprotein B-100Cholesterol, LDL

Stichwörter der Autor:innen

ST-elevation myocardial infarction (STEMI)acute coronary syndrome (ACS)cholesterolcoenzyme Q10fatty acid-binding protein 3 (FABP3)myopathystatinubiquinone

Substanzen

Ubiquinonecoenzyme Q10Hydroxymethylglutaryl-CoA Reductase InhibitorsBiomarkersFatty Acid Binding Protein 3Lipoproteins, LDLApolipoprotein B-100Cholesterol, LDL

Autor:innen und Institutionen

  • Centre of Cardiovascular Diseases and Internal Medicine, Borsod-Abauj-Zemplen County Central Hospital and University Teaching Hospital, Szentpéteri kapu 72-76, 3526 Miskolc, Hungary.
  • Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Proteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
  • Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
  • Doctoral School of Health Sciences, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
  • Institute of Health Studies, Faculty of Health Sciences, University of Debrecen, Kassai út 26, 4032 Debrecen, Hungary.

ORCID-Profile: Hajnalka Lorincz, Eva Csosz, Mariann Harangi, Gergely Gyorgy Nagy

Förderung

  • National Research, Development and Innovation Office - NKFIH
  • National Research, Development, and Innovation Office—NKFIH

Zitieren

APA

Csengo, E., Lorincz, H., Csosz, E., Guba, A., Karai, B., Toth, J., Csiha, S., Paragh, G., Harangi, M., & Nagy, G. G. (2024). Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial Infarction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010106

Vancouver

Csengo E, Lorincz H, Csosz E, Guba A, Karai B, Toth J, et al. Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial Infarction. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010106

BibTeX
@article{Csengo2024,
  author = {Csengo, Erika and Lorincz, Hajnalka and Csosz, Eva and Guba, Andrea and Karai, Bettina and Toth, Judit and Csiha, Sara and Paragh, Gyorgy and Harangi, Mariann and Nagy, Gergely Gyorgy},
  title = {Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial Infarction},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010106}
}
Kostenlos starten →